azacitidine and givinostat hydrochloride

azacitidine has been researched along with givinostat hydrochloride in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Anagnostou, V; Ballew, M; Baylin, SB; Chiappinelli, KB; DeStefano Shields, CE; Hellmann, MD; Hicks, J; Niknafs, N; Stone, M; Strick, R; Strissel, PL; Topper, MJ; Tran, PT; Vaz, M; Velculescu, VE; Wenzel, A; Yen, RC; Zahnow, CA	1

Other Studies

1 other study(ies) available for azacitidine and givinostat hydrochloride

Article	Year
Epigenetic Therapy Ties MYC Depletion to Reversing Immune Evasion and Treating Lung Cancer. Cell, 2017, Nov-30, Volume: 171, Issue:6 Topics: Animals; Antigen Presentation; Antineoplastic Agents; Azacitidine; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Drug Therapy, Combination; Histone Deacetylase Inhibitors; Hydroxamic Acids; Immunotherapy; Lung Neoplasms; Mice; T-Lymphocytes; Transcriptome; Tumor Escape; Tumor Microenvironment	2017

Article

Year

Epigenetic Therapy Ties MYC Depletion to Reversing Immune Evasion and Treating Lung Cancer.

Cell, 2017, Nov-30, Volume: 171, Issue:6

Topics: Animals; Antigen Presentation; Antineoplastic Agents; Azacitidine; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Drug Therapy, Combination; Histone Deacetylase Inhibitors; Hydroxamic Acids; Immunotherapy; Lung Neoplasms; Mice; T-Lymphocytes; Transcriptome; Tumor Escape; Tumor Microenvironment

2017